Tag Archives: Reuters

Johnson & Johnson Tumbles as Pfizer Set to Launch Remicade Biosimilar; Solid 3rd Quarter Doesn’t Quell Market’s Overreaction

Thriving pharmaceutical sales drove stellar quarterly results for Johnson & Johnson (New Brunswick NJ), but the company’s shares fell 3% so far this week on worries that its smash hit,… Read more »

Zika Funding Plan Announced By Obama Officials; But Why the Long Delay After Congress Finally Voted Them?

US health officials outlined on Tuesday (October 18, 2016) how they planned to divide up $1.1 billion in funds approved by Congress to fight the Zika virus, including repaying $44.25… Read more »

Glaxo Settles Bribery Charges with SEC for $20 Million; Cozy Relation of Pharma with Docs a Thing of the Past?

GlaxoSmithKline PLC (London) will pay $20 million to settle civil charges that it masked bribes to foreign officials in China by disguising them as legitimate travel, entertainment and marketing expenses,… Read more »

Bloomberg: Data Show US Devotes Disproportionate Resources to Healthcare with Lackluster Results

The U.S. healthcare system remains among the least-efficient in the world, ranking 50th out of 55 countries in 2014, according to a Bloomberg index that assesses life expectancy, healthcare spending… Read more »

Anthem, Cigna Clash Over Merger Terms; AMA Weighs in on Pending Deals

The Department of Justice is asking a federal judge to compel Anthem Inc. (Indianapolis IN) and Cigna Inc. (Bloomfield CT) to produce letters they have sent accusing each other of breaching an… Read more »

FDA Approves First Muscular Dystrophy Drug Despite Thumbs Down by Scientific Panel

Federal regulators granted tentative approval to the first drug for muscular dystrophy, following an intense public campaign from patients and doctors who pushed for the largely unproven medication. The approval… Read more »

Google Parent, Sanofi to Invest $500 Million in Diabetes Joint Venture

French drugmaker Sanofi SA (Paris) and Verily, the life sciences unit of Google parent Alphabet Inc. (Mountain View CA) on Monday said they would invest about $500 million in a… Read more »

U.S. Study Raises New Concern for Zika Spread; Congress Back, but Just 19 Days Left to Solve Zika Funding Impasse.

According to a Reuters report, a new study has found genetic fragments of Zika in the eyes and the tears of laboratory mice infected with the virus–a finding that offers… Read more »

Mylan Plans Generic EpiPen to Calm Pricing Outrage; Feels More Like a PR Move

Mylan NV’s latest attempt to deflect criticism over the price of allergy shot EpiPen failed to get the drugmaker out of the crosshairs of Congress this week. Last week, Chief… Read more »

Drugmakers’ Pricing Power Helped by Exclusivity Rights: JAMA

The U.S., which spends more on drugs than any other country, might contain costs by limiting market exclusivity for brand-name medicines and changing coverage requirements for government health plans, some… Read more »